Matthew W. Lux
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Matthew W. Lux has a total of 131 co-authors. Here are the top co-authors by number of shared publications:
Casey B. Bernhards
Applied Synthetic Biology and Olfaction, U.S. Army DEVCOM Chemical Biological Center
8 shared publicationsPeter A. Emanuel
US Army Combat Capabilities Development Command Chemical Biological Center
7 shared publications- Marilyn Slininger Lee
US Army Combat Capabilities Development Command Chemical Biological Center, Aberdeen Proving Ground, MD 21010, USA
6 shared publications Stephanie D. Cole
Applied Synthetic Biology and Olfaction, U.S. Army DEVCOM Chemical Biological Center
6 shared publicationsSteven M. Blum
Applied Synthetic Biology and Olfaction, U.S. Army DEVCOM Chemical Biological Center
6 shared publicationsAlvin T. Liem
U.S. Army Combat Capabilities Development Command Chemical Biological Center, Aberdeen Proving Ground, Maryland 21010, United States
5 shared publications
Latest Publications
- 17 November 2026
- Published by Elsevier in Metabolic Engineering
Microliter to liter scale engineering of cell-free 1,2,4-butanetriol biosynthesis
- 17 November 2026
- Published by Elsevier in Metabolic Engineering
Microliter to liter scale engineering of cell-free 1,2,4-butanetriol biosynthesis
- Open Access
Cell-free pathway prototyping enables cost-effective biomanufacturing of 1,2,4-butanetriol at the 1-L scale
Biomanufacturing offers sustainable alternatives to chemical synthesis under lower temperatures and pressures than traditional catalytic methods. However, the slow pace and iterative engineering bottlenecks of cell strain development restrict the feasible biological design space. Cell-free systems circumvent these constraints, providing a flexible and high-throughput screening approach to accelerate pathway prototyping and enzyme optimization but are not typically used for manufacturing scale-up. To understand the scalability of cell-free biosynthesis, we establish an end-to-end fully cell-free architecture to discover, develop, and scale the biosynthesis of 1,2,4-butanetriol (BT), a high-value industrial platform chemical. First, we systematically screened ~150 enzymes across the 4-step pathway from xylose to BT to identify highly active homologs for each reaction. Next, we applied statistical Design of Experiments to optimize reaction formulations for cost and titer. Finally, the maximum-titer and minimum-cost formulations were scaled up across five orders of magnitude, from 10-µL to 1-L reactions. This resulted in peak volumetric productivities of ~1 g/L/h and yields over 13 g of BT in a single 1-L reaction, with raw substrate costs totaling just $3.00 per liter. This work expands the diversity of enzymes tested for BT synthesis and establishes a blueprint for advancing industrial biochemical manufacturing fully in vitro .
Open AccessCell-free pathway prototyping enables cost-effective biomanufacturing of 1,2,4-butanetriol at the 1-L scale
Biomanufacturing offers sustainable alternatives to chemical synthesis under lower temperatures and pressures than traditional catalytic methods. However, the slow pace and iterative engineering bottlenecks of cell strain development restrict the feasible biological design space. Cell-free systems circumvent these constraints, providing a flexible and high-throughput screening approach to accelerate pathway prototyping and enzyme optimization but are not typically used for manufacturing scale-up. To understand the scalability of cell-free biosynthesis, we establish an end-to-end fully cell-free architecture to discover, develop, and scale the biosynthesis of 1,2,4-butanetriol (BT), a high-value industrial platform chemical. First, we systematically screened ~150 enzymes across the 4-step pathway from xylose to BT to identify highly active homologs for each reaction. Next, we applied statistical Design of Experiments to optimize reaction formulations for cost and titer. Finally, the maximum-titer and minimum-cost formulations were scaled up across five orders of magnitude, from 10-µL to 1-L reactions. This resulted in peak volumetric productivities of ~1 g/L/h and yields over 13 g of BT in a single 1-L reaction, with raw substrate costs totaling just $3.00 per liter. This work expands the diversity of enzymes tested for BT synthesis and establishes a blueprint for advancing industrial biochemical manufacturing fully in vitro .
- Open Access
- 5 April 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (6) , 1615-1623
Impact of Process Interruptions in the Production of Lysates for Cell‐Free Expression Systems
Cell‐free gene expression systems offer cell‐like functionalities outside the confines of the cell, garnering increasing interest for applications from biomanufacturing to sensing. As applications expand, the need to implement economically scaled processes to produce cellular lysates grows. The protocols to produce these cellular lysates are complex, and the impact of altering many of the process variables remains understudied. Here, we set out to evaluate the effect of extended incubations at several points in the extract preparation process with the goal of identifying breakpoints that would enable flexibility in process implementation. As a model, we prepared lysates from 50 L cultures instead of typical 1 L volumes. We produced 72 lysates, 36 that were incubated overnight before and after culture centrifugation, and 36 that were incubated with and without a run‐off reaction, each across different temperatures. We found that incubations before and after culture centrifugation substantially increased variability between culture replicates but did not reduce cell‐free protein synthesis activity, contrary to conventional wisdom that materials should be kept cold as much as possible throughout the process. We also observed that omitting the run‐off reaction reduced yields but resulted in lysates that were robust to incubation up to room temperature overnight. When a run‐off reaction was included, activity dropped both as a function of duration and temperature, and the overall variability increased. Our work offers potential options for flexibility in implementing lysate production processes and motivates further investigation into how key processing steps relate to cell‐free expression activity.
- 5 April 2026
- Published by Wiley in Biotechnology and Bioengineering
- Vol. 123 (6) , 1615-1623
Open AccessImpact of Process Interruptions in the Production of Lysates for Cell‐Free Expression Systems
Cell‐free gene expression systems offer cell‐like functionalities outside the confines of the cell, garnering increasing interest for applications from biomanufacturing to sensing. As applications expand, the need to implement economically scaled processes to produce cellular lysates grows. The protocols to produce these cellular lysates are complex, and the impact of altering many of the process variables remains understudied. Here, we set out to evaluate the effect of extended incubations at several points in the extract preparation process with the goal of identifying breakpoints that would enable flexibility in process implementation. As a model, we prepared lysates from 50 L cultures instead of typical 1 L volumes. We produced 72 lysates, 36 that were incubated overnight before and after culture centrifugation, and 36 that were incubated with and without a run‐off reaction, each across different temperatures. We found that incubations before and after culture centrifugation substantially increased variability between culture replicates but did not reduce cell‐free protein synthesis activity, contrary to conventional wisdom that materials should be kept cold as much as possible throughout the process. We also observed that omitting the run‐off reaction reduced yields but resulted in lysates that were robust to incubation up to room temperature overnight. When a run‐off reaction was included, activity dropped both as a function of duration and temperature, and the overall variability increased. Our work offers potential options for flexibility in implementing lysate production processes and motivates further investigation into how key processing steps relate to cell‐free expression activity.
- Open Access
Semi-automated Production of Cell-free Biosensors
Cell-free synthetic biology biosensors have potential as effective in vitro diagnostic technologies for the detection of chemical compounds such as toxins and human health biomarkers. They have several advantages over conventional laboratory-based diagnostic approaches, including being able to be assembled, freeze-dried, distributed, and then used at the point-of-need. This makes them an attractive platform for cheap and rapid chemical detection across the globe. Though promising, a major challenge is scaling up biosensor manufacturing to meet the needs of their multiple uses. Currently, cell-free biosensor assembly during lab-scale development is mostly performed manually by the operator, leading to quality control and performance variability issues. Here we explore the use of liquid handling robotics to manufacture cell-free biosensor reactions. We compare both manual and semi-automated reaction assembly approaches using the Opentrons OT-2 liquid handling platform on two different cell-free gene expression assay systems that constitutively produce colorimetric (LacZ) or fluorescent (GFP) signals. We test the designed protocol by constructing an entire 384-well plate of fluoride sensing cell-free biosensors and demonstrate that they perform closely to expected detection outcomes.
Open AccessSemi-automated Production of Cell-free Biosensors
Cell-free synthetic biology biosensors have potential as effective in vitro diagnostic technologies for the detection of chemical compounds such as toxins and human health biomarkers. They have several advantages over conventional laboratory-based diagnostic approaches, including being able to be assembled, freeze-dried, distributed, and then used at the point-of-need. This makes them an attractive platform for cheap and rapid chemical detection across the globe. Though promising, a major challenge is scaling up biosensor manufacturing to meet the needs of their multiple uses. Currently, cell-free biosensor assembly during lab-scale development is mostly performed manually by the operator, leading to quality control and performance variability issues. Here we explore the use of liquid handling robotics to manufacture cell-free biosensor reactions. We compare both manual and semi-automated reaction assembly approaches using the Opentrons OT-2 liquid handling platform on two different cell-free gene expression assay systems that constitutively produce colorimetric (LacZ) or fluorescent (GFP) signals. We test the designed protocol by constructing an entire 384-well plate of fluoride sensing cell-free biosensors and demonstrate that they perform closely to expected detection outcomes.
- Open Access
High-Throughput Optimization of Paper-Based Cell-Free Biosensors
Cell-free expression systems maintain core cellular processes without intact cells and offer attractive properties as point-of-need biosensors. The ability to lyophilize, store, and use on-demand make these sensors usable in the field, and the lack of membranes means that there are no analyte transport issues and that new sensors can be deployed by simply adding a different DNA molecule. The lack of membranes also means that sensor designs and reaction optimizations can be screened in high throughput. While shelf stability has been demonstrated in specific cases using additives, these approaches are not universal to the myriad cell-free expression methods and formats. Here, we present new high-throughput screening methods to optimize cell-free expression formulations when embedded into paper for use as sensors. Our method leverages acoustic liquid handling to dispense reactions onto 384-well paper ticket formats and machine vision to quantify reaction performance from a colorimetric reporter enzyme. The throughput enabled shifts the bottleneck from experimental execution to selecting the experiments to execute; we therefore implement design-of-experiments to optimize the information gained from each design-build-test-learn cycle. We used these approaches to first optimize the performance of a low-cost cell-free expression formulation that was initially non-functional when embedded in paper, then further optimize it for tolerance to exposure to heat. With only 2 rounds of experimentation lasting 4 days total for each goal, the result are an energy mixture with 8% of the materials cost of a commonly used version and a formulation of excipients that maintain 60% of activity after 6 hours of storage at 50 °C and. Finally, we showcase the use of the cost-optimized formulation in a 3D-printed paperfluidic device where it outperforms the standard formulation at much lower cost.
Open AccessHigh-Throughput Optimization of Paper-Based Cell-Free Biosensors
Cell-free expression systems maintain core cellular processes without intact cells and offer attractive properties as point-of-need biosensors. The ability to lyophilize, store, and use on-demand make these sensors usable in the field, and the lack of membranes means that there are no analyte transport issues and that new sensors can be deployed by simply adding a different DNA molecule. The lack of membranes also means that sensor designs and reaction optimizations can be screened in high throughput. While shelf stability has been demonstrated in specific cases using additives, these approaches are not universal to the myriad cell-free expression methods and formats. Here, we present new high-throughput screening methods to optimize cell-free expression formulations when embedded into paper for use as sensors. Our method leverages acoustic liquid handling to dispense reactions onto 384-well paper ticket formats and machine vision to quantify reaction performance from a colorimetric reporter enzyme. The throughput enabled shifts the bottleneck from experimental execution to selecting the experiments to execute; we therefore implement design-of-experiments to optimize the information gained from each design-build-test-learn cycle. We used these approaches to first optimize the performance of a low-cost cell-free expression formulation that was initially non-functional when embedded in paper, then further optimize it for tolerance to exposure to heat. With only 2 rounds of experimentation lasting 4 days total for each goal, the result are an energy mixture with 8% of the materials cost of a commonly used version and a formulation of excipients that maintain 60% of activity after 6 hours of storage at 50 °C and. Finally, we showcase the use of the cost-optimized formulation in a 3D-printed paperfluidic device where it outperforms the standard formulation at much lower cost.
- Open Access
- 11 March 2024
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 13 (4) , 1152-1164
Cell-Free Protein Expression in Polymer Materials
While synthetic biology has advanced complex capabilities such as sensing and molecular synthesis in aqueous solutions, important applications may also be pursued for biological systems in solid materials. Harsh processing conditions used to produce many synthetic materials such as plastics make the incorporation of biological functionality challenging. One technology that shows promise in circumventing these issues is cell-free protein synthesis (CFPS), where core cellular functionality is reconstituted outside the cell. CFPS enables genetic functions to be implemented without the complications of membrane transport or concerns over the cellular viability or release of genetically modified organisms. Here, we demonstrate that dried CFPS reactions have remarkable tolerance to heat and organic solvent exposure during the casting processes for polymer materials. We demonstrate the utility of this observation by creating plastics that have spatially patterned genetic functionality, produce antimicrobials in situ, and perform sensing reactions. The resulting materials unlock the potential to deliver DNA-programmable biofunctionality in a ubiquitous class of synthetic materials.
- 11 March 2024
- Published by American Chemical Society (ACS) in ACS Synthetic Biology
- Vol. 13 (4) , 1152-1164
Open AccessCell-Free Protein Expression in Polymer Materials
While synthetic biology has advanced complex capabilities such as sensing and molecular synthesis in aqueous solutions, important applications may also be pursued for biological systems in solid materials. Harsh processing conditions used to produce many synthetic materials such as plastics make the incorporation of biological functionality challenging. One technology that shows promise in circumventing these issues is cell-free protein synthesis (CFPS), where core cellular functionality is reconstituted outside the cell. CFPS enables genetic functions to be implemented without the complications of membrane transport or concerns over the cellular viability or release of genetically modified organisms. Here, we demonstrate that dried CFPS reactions have remarkable tolerance to heat and organic solvent exposure during the casting processes for polymer materials. We demonstrate the utility of this observation by creating plastics that have spatially patterned genetic functionality, produce antimicrobials in situ, and perform sensing reactions. The resulting materials unlock the potential to deliver DNA-programmable biofunctionality in a ubiquitous class of synthetic materials.
- Open Access
Cell-Free Optimized Production of Protoporphyrin IX
Background: The asymmetric and aromatic structures of porphyrins enable semiconducting properties allowing them to absorb light to initiate complex photocatalytic activity. These properties coupled with biological origins have garnered these molecules and their derivatives wide interest as a biotechnological platform. However, porphyrin production in cells is challenging due to the limited titer, long production timescales, and difficult purification. Results: A cell-free metabolic engineering platform was constructed to produce protoporphyrin IX (PPIX) from E. coli crude extracts. Using acoustic liquid-handling, design of experiments for high-throughput buffer optimization and co-culturing techniques for extract production, our cell-free reactions effectively produced 0.109 mg/mL quantities of porphyrins. Conclusions: The use of cell-free metabolic engineering as a bioproduction platform could improve the production of toxic or inefficient biomolecules such as PPIX. The engineering strategies including DOE and co-culturing applied in this study provide a roadmap towards increasing the scale of cell-free metabolic engineering by elucidating batch to batch variability, as well as the need for batch specific optimization of reaction conditions.
Open AccessCell-Free Optimized Production of Protoporphyrin IX
Background: The asymmetric and aromatic structures of porphyrins enable semiconducting properties allowing them to absorb light to initiate complex photocatalytic activity. These properties coupled with biological origins have garnered these molecules and their derivatives wide interest as a biotechnological platform. However, porphyrin production in cells is challenging due to the limited titer, long production timescales, and difficult purification. Results: A cell-free metabolic engineering platform was constructed to produce protoporphyrin IX (PPIX) from E. coli crude extracts. Using acoustic liquid-handling, design of experiments for high-throughput buffer optimization and co-culturing techniques for extract production, our cell-free reactions effectively produced 0.109 mg/mL quantities of porphyrins. Conclusions: The use of cell-free metabolic engineering as a bioproduction platform could improve the production of toxic or inefficient biomolecules such as PPIX. The engineering strategies including DOE and co-culturing applied in this study provide a roadmap towards increasing the scale of cell-free metabolic engineering by elucidating batch to batch variability, as well as the need for batch specific optimization of reaction conditions.
- Open Access
Cell-Free Protein Expression in Polymer Materials
While synthetic biology has advanced complex capabilities like sensing and molecule synthesis in aqueous solutions, important applications may also be pursued for biological systems in solid materials. Harsh processing conditions used to produce many synthetic materials such as plastics makes incorporation of biological functionality challenging. One technology that shows promise in circumventing these issues is cell-free protein synthesis (CFPS), where core cellular functionality is reconstituted outside the cell. CFPS enables genetic functions to be implemented without the complications of membrane transport or concerns over cellular viability or release of genetically modified organisms. Here we demonstrate that dried CFPS reactions have remarkable tolerance to heat and organic solvent exposure during the casting processes for polymer materials. We demonstrate the utility of this observation by creating plastics that have spatially patterned genetic functionality, produce antimicrobials in situ , and perform sensing reactions. The resulting materials unlock the potential to deliver DNA-programmable bio-functionality in a ubiquitous class of synthetic materials.
Open AccessCell-Free Protein Expression in Polymer Materials
While synthetic biology has advanced complex capabilities like sensing and molecule synthesis in aqueous solutions, important applications may also be pursued for biological systems in solid materials. Harsh processing conditions used to produce many synthetic materials such as plastics makes incorporation of biological functionality challenging. One technology that shows promise in circumventing these issues is cell-free protein synthesis (CFPS), where core cellular functionality is reconstituted outside the cell. CFPS enables genetic functions to be implemented without the complications of membrane transport or concerns over cellular viability or release of genetically modified organisms. Here we demonstrate that dried CFPS reactions have remarkable tolerance to heat and organic solvent exposure during the casting processes for polymer materials. We demonstrate the utility of this observation by creating plastics that have spatially patterned genetic functionality, produce antimicrobials in situ , and perform sensing reactions. The resulting materials unlock the potential to deliver DNA-programmable bio-functionality in a ubiquitous class of synthetic materials.
- 28 July 2023
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 197,p. e65014
Cell-Free Expression Systems: Methods of Production and Use
ARTICLES DISCUSSED: Grasemann, L., Lavickova, B., Elizondo-Cantú, M. C., Maerkl, S. J. OnePot PURE cell-free system. Journal of Visualized Experiments. (172), doi:10.3791/62625 (2021). Smith, P. E. J., Slouka, T., Dabbas, M., Oza, J. P. From cells to cell-free protein synthesis within 24 hours using cell-free autoinduction workflow. Journal of Visualized Experiments. (173), doi:10.3791/62866 (2021). Cooper, R. M., Tonooka, T., Didovyk, A., Hasty, J. Rapid, affordable, and uncomplicated production of bacterial cell-free lysate. Journal of Visualized Experiments. (176), doi:10.3791/62753 (2021). Dopp, J. L., Reuel, N. F. Rapid, enzymatic methods for amplification of minimal, linear templates for protein prototyping using cell-free systems. Journal of Visualized Experiments. (172), doi:10.3791/62728 (2021). McManus, J. B. et al. Rapid characterization of genetic parts with cell-free systems. Journal of Visualized Experiments. (174), doi:10.3791/62816 (2021). Toh, M., Chengan, K., Hanson, T., Freemont, P. S., Moore, S. J. A high-yield streptomyces transcription-translation toolkit for synthetic biology and natural product applications. Journal of Visualized Experiments. (175), doi:10.3791/63012 (2021). Dinglasan, J. L. N., Reeves, D. T., Hettich, R. L., Doktycz, M. J. Liquid chromatography coupled to refractive index or mass spectrometric detection for metabolite profiling in lysate-based cell-free systems. Journal of Visualized Experiments. (175), doi:10.3791/62852 (2021). Drachuk, I., Harbaugh, S., Kelley-Loughnane, N., Chávez, J. L. Preparation of multifunctional silk-based microcapsules loaded with DNA plasmids encoding RNA aptamers and riboswitches. Journal of Visualized Experiments. (176), doi:10.3791/62854 (2021). Jaenes, K. et al. Design to implementation study for development and patient validation of paper-based toehold switch diagnostics. Journal of Visualized Experiments. (184), doi:10.3791/63223 (2022).
- 28 July 2023
- Published by MyJove Corporation in Journal of Visualized Experiments
- No. 197,p. e65014
Cell-Free Expression Systems: Methods of Production and Use
ARTICLES DISCUSSED: Grasemann, L., Lavickova, B., Elizondo-Cantú, M. C., Maerkl, S. J. OnePot PURE cell-free system. Journal of Visualized Experiments. (172), doi:10.3791/62625 (2021). Smith, P. E. J., Slouka, T., Dabbas, M., Oza, J. P. From cells to cell-free protein synthesis within 24 hours using cell-free autoinduction workflow. Journal of Visualized Experiments. (173), doi:10.3791/62866 (2021). Cooper, R. M., Tonooka, T., Didovyk, A., Hasty, J. Rapid, affordable, and uncomplicated production of bacterial cell-free lysate. Journal of Visualized Experiments. (176), doi:10.3791/62753 (2021). Dopp, J. L., Reuel, N. F. Rapid, enzymatic methods for amplification of minimal, linear templates for protein prototyping using cell-free systems. Journal of Visualized Experiments. (172), doi:10.3791/62728 (2021). McManus, J. B. et al. Rapid characterization of genetic parts with cell-free systems. Journal of Visualized Experiments. (174), doi:10.3791/62816 (2021). Toh, M., Chengan, K., Hanson, T., Freemont, P. S., Moore, S. J. A high-yield streptomyces transcription-translation toolkit for synthetic biology and natural product applications. Journal of Visualized Experiments. (175), doi:10.3791/63012 (2021). Dinglasan, J. L. N., Reeves, D. T., Hettich, R. L., Doktycz, M. J. Liquid chromatography coupled to refractive index or mass spectrometric detection for metabolite profiling in lysate-based cell-free systems. Journal of Visualized Experiments. (175), doi:10.3791/62852 (2021). Drachuk, I., Harbaugh, S., Kelley-Loughnane, N., Chávez, J. L. Preparation of multifunctional silk-based microcapsules loaded with DNA plasmids encoding RNA aptamers and riboswitches. Journal of Visualized Experiments. (176), doi:10.3791/62854 (2021). Jaenes, K. et al. Design to implementation study for development and patient validation of paper-based toehold switch diagnostics. Journal of Visualized Experiments. (184), doi:10.3791/63223 (2022).
- Open Access
- 1 January 2023
- Published by Oxford University Press (OUP) in Synthetic Biology
- Vol. 8 (1) , ysad015
Special issue: reproducibility in synthetic biology
A lack of reproducibility in many areas of science has been shown in recent years, raising broad concerns over the validity of research output and undermining trust in literature results. Synthetic biology, a field that endeavors to make biology more engineerable, should be at the forefront of ensuring reproducibility in the life sciences, yet to date little attention has been paid to the topic in the literature. As synthetic biology moves through its third decade, delivering on the immense promise of the field requires transitioning early research into real-world impact, which starts with better understanding and demonstrating reproducibility. This Special Issue is the first of its kind to shine a light on reproducibility in synthetic biology by providing current work in the space and offering views on what is needed to move forward.
- 1 January 2023
- Published by Oxford University Press (OUP) in Synthetic Biology
- Vol. 8 (1) , ysad015
Open AccessSpecial issue: reproducibility in synthetic biology
A lack of reproducibility in many areas of science has been shown in recent years, raising broad concerns over the validity of research output and undermining trust in literature results. Synthetic biology, a field that endeavors to make biology more engineerable, should be at the forefront of ensuring reproducibility in the life sciences, yet to date little attention has been paid to the topic in the literature. As synthetic biology moves through its third decade, delivering on the immense promise of the field requires transitioning early research into real-world impact, which starts with better understanding and demonstrating reproducibility. This Special Issue is the first of its kind to shine a light on reproducibility in synthetic biology by providing current work in the space and offering views on what is needed to move forward.